6550--Reagents and consumables for Oncology

Closed Pre-Solicitation Posted

Solicitation number
36C26226Q0227
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Department of Veterans Affairs VA Greater Los Angeles Healthcare System Los Angeles CA 90073, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Integrated Service Network 22 (VISN 22) is seeking sources for reagents and consumables for oncology applications to support the VA Greater Los Angeles Healthcare System. The procurement targets in-vitro diagnostic substances and laboratory supplies specifically compatible with Ion Torrent S5, Ion Torrent Chef System, and Ion Torrent Genexus platforms, including Oncomine Precision Assay kits, sequencing kits, assay materials, and related consumables. Prospective vendors must be authorized resellers, distributors, or dealers of Original Equipment Manufacturers (OEMs), with no remanufactured or gray market items acceptable. The procurement is classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) with a small business size standard of 1,250 employees, and respondents should provide evidence of their business type (such as SDVOSB or VOSB status if applicable), manufacturing or distribution capabilities, existing federal contract holdings, and ability to meet salient characteristics of required products. The Request for Information (RFI) response deadline is January 2, 2026 at 9:00 AM Pacific Time, with submissions directed to Carlos Magana at Carlos.Magana@va.gov, referencing solicitation number 36C26226Q0227.

No set-aside designation has been applied to this procurement opportunity, and no incumbent contractor information is provided in the pre-solicitation materials. The solicitation specifies a line-item list of 24 distinct products from Thermo Fisher Scientific, each with associated manufacturer part numbers and required quantities as detailed in Attachment A, with comprehensive specifications outlined in the Statement of Work. While specific award values or budget ranges are not disclosed in the pre-solicitation documentation, the scope encompasses molecular oncology testing supplies designed to identify 69 specific genes across myeloid and solid tumor categories, including genes such as ABL1, BRAF, KRAS, TP53, and AKT1. Vendor requirements include adherence to strict information security protocols, compliance with federal regulations, and completion of background investigations for any personnel who will access VA computer systems. The contract will be executed through VISN 22's Network Contracting Office in Long Beach, California, with operations during standard federal hours of 7:30 AM to 5:00 PM, Monday through Friday, excluding federal holidays.

Notice text

***View attachments for details***

Files

File Type Posted
SOW.docx DOCX document
36C26226Q0227.docx DOCX document
RFI Doc.docx DOCX document
Attachment A.xlsx XLSX spreadsheet

Similar open opportunities

Opportunity Agency Set-aside Responses due
Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC Seattle, Washington 98108, United States · NAICS 325413 Veterans Integrated Service Network 20 No set-aside
Q301--NEW – STX Specialized Molecular Residual Disease Testing NAICS 621511 Veterans Integrated Service Network 17 No set-aside
6550--VISN 4 Coagulation Testing Visn 4 VA Medical Facilities Addresses Provided in PWS · NAICS 334516 Veterans Integrated Service Network 4 No set-aside
6550--Cepheid GeneXpert Testing Supplies Beckley Vamc Clarksburg Vamc Vamhcs Washington Vamc · NAICS 325413 Veterans Integrated Service Network 5 No set-aside
6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ Department of Veterans Affairs VA North Atlantic Health Network HSA 1.3 Various Locations, United States · NAICS 325413 Veterans Integrated Service Network 5 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity